Beth is a European qualified patent attorney in our Life Sciences and Chemistry group. Beth’s practice spans a variety of fields in the life sciences. Key areas of practice include stem cells, antibodies, tissue engineering, CRISPR-Cas9 and RNA technologies. She also has valuable in-house experience gained during a secondment at a multinational pharmaceutical company.
Beth co-ordinates worldwide patent prosecution of large portfolios and complex IP strategies for large multinationals. She also works closely with her start-up clients to formulate IP strategies that support the client’s business and commercial needs, as well as preparing and filing foundational patent applications and assisting with freedom-to-operate analysis. Beth has experience of working with clients throughout all stages of clinical trial candidate development, including supporting them to obtain valuable patent and Supplementary Protection Certificate (SPC) protection.
In addition to her work in the Life Sciences and Chemistry group, Beth sits on the board of our Innovation for All Foundation, Kilburn & Strode’s charity fund which is dedicated to allocating a percentage of our annual profits to those in need.
Beth holds a PhD in Cardiovascular Sciences. Her research focused on phenotyping induced pluripotent stem cell-derived cardiomyocytes harbouring cardiomyopathy disease-causing mutations. She has additional research experience spanning a variety of scientific fields, including immuno-oncology and diabetes.